- Home
- CNTA vs ENVX Comparison
CNTA vs ENVX Comparison
Compare CNTA & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- ENVX
- Stock Information
- Founded
- CNTA 2020
- ENVX 2006
- Country
- CNTA United Kingdom
- ENVX United States
- Employees
- CNTA N/A
- ENVX N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- ENVX Industrial Machinery/Components
- Sector
- CNTA Health Care
- ENVX Miscellaneous
- Exchange
- CNTA Nasdaq
- ENVX Nasdaq
- Market Cap
- CNTA 2.3B
- ENVX 1.9B
- IPO Year
- CNTA 2021
- ENVX N/A
- Fundamental
- Price
- CNTA $21.81
- ENVX $8.14
- Analyst Decision
- CNTA Strong Buy
- ENVX Strong Buy
- Analyst Count
- CNTA 11
- ENVX 9
- Target Price
- CNTA $30.60
- ENVX $18.11
- AVG Volume (30 Days)
- CNTA 1.5M
- ENVX 7.7M
- Earning Date
- CNTA 11-11-2025
- ENVX 10-28-2025
- Dividend Yield
- CNTA N/A
- ENVX N/A
- EPS Growth
- CNTA N/A
- ENVX N/A
- EPS
- CNTA N/A
- ENVX N/A
- Revenue
- CNTA $15,000,000.00
- ENVX $26,600,000.00
- Revenue This Year
- CNTA N/A
- ENVX $47.50
- Revenue Next Year
- CNTA N/A
- ENVX $205.50
- P/E Ratio
- CNTA N/A
- ENVX N/A
- Revenue Growth
- CNTA 118.88
- ENVX 60.04
- 52 Week Low
- CNTA $9.60
- ENVX $4.61
- 52 Week High
- CNTA $23.24
- ENVX $16.49
- Technical
- Relative Strength Index (RSI)
- CNTA 71.02
- ENVX 27.66
- Support Level
- CNTA $15.01
- ENVX $7.70
- Resistance Level
- CNTA $23.24
- ENVX $9.50
- Average True Range (ATR)
- CNTA 1.23
- ENVX 0.41
- MACD
- CNTA 0.59
- ENVX -0.09
- Stochastic Oscillator
- CNTA 82.62
- ENVX 14.31
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About ENVX Enovix Corporation
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.